You are about to leave an AbbVie Canada site, a Web site maintained by AbbVie Corporation.

This link is provided for your convenience only. AbbVie Corporation takes no responsibility for the content of any Web site maintained by any third party and makes no representation as to the accuracy or completeness of any information contained on this or any subsequent link.

Do you wish to leave this site?

Yes No

You are here

SOLACE - Hidradenitis Suppurativa

Canadian Adalimumab Post Marketing Observational Epidemiological Study: Assessing Adalimumab Real-life Effectiveness and Impact on Moderate to Severe Hidradenitis Suppurativa (HS) Burden of Illness – SOLACE

    Status Recruiting
    Related Conditions
    Hidradenitis Suppurativa

Enrollment Details

Phases: 

  • I
  • II
  • III
  • IV
Study Type:  Observational

This is a type IV phase trial.

Protocol ID
P15-696

Brief summary

Top

The SOLACE study will help us generate and advance scientific knowledge of real-life management of hidradenitis suppurativa and the condition’s burden on people with moderate to severe HS. It will aim to demonstrate the real-life effectiveness (how well something works) of HUMIRA on productivity, and physical and psychological quality of life. Finally, it will see how the use of HUMIRA affects patients’ use of health care resources (visit to hospital Emergency Room, hospitalization, help at home with regular activities, wound care, etc.) and associated costs in Canada. 

Canada: 17

0
Barrie, ON
1
Richmond Hill, ON
2
Peterborough, ON
3
Markham, ON
4
Waterloo, ON
5
Laval , QC
6
Fredericton, NB
7
St. John’s, NL
8
St-John's, NL
9
St-Hyacinthe, QC
10
St. John’s, NL
11
Winnipeg, MB
12
Saint-Jérôme, QC
13
Calgary, AB
14
Verdun, QC
15
Winnipeg, MB
16
Edmonton, AB
Would you like to know more about this trial?

Study Design

  • The general design that describes the strategy for identifying and following up with participants during observational studies.
    ?

    Observational Model

    Open-label observational study

  • The relationship between the observation period and the time of patient enrollment. Time perspective can be prospective: looking forward using periodic observations usually collected following patient enrollment, or retrospective: looking back using observations usually collected prior to patient selection and enrollment.
    ?

    Time Perspective

    Perspective

  • Eligibility Criteria

    These are the major criteria to enter the study. Your study coordinator can explain any other contributing factors. Some of these medical terms may be difficult to understand – your study coordinator can clarify them for you.

    Eligibility Criteria

    These are the major criteria to enter the study. Your study coordinator can explain any other contributing factors. Some of these medical terms may be difficult to understand – your study coordinator can clarify them for you.